RxDoctor Payments DataLook up a doctor →

Jean Levin

Nurse Practitioner · du Bois, PANPI 1881794089

Payments from drug & device makers

$14,690in general payments, 2019–2025

Across 413 payments — averaging $35.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$5K
  • Seagen Inc.$2K
  • Incyte Corporation$665
  • Daiichi Sankyo Inc.$595
  • Novartis$525
  • AbbVie$448
  • plus $5K from 51 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer25$5,474
Seagen Inc.15$2,303
Incyte Corporation39$665
Daiichi Sankyo Inc.30$595
Novartis30$525
AbbVie20$448
Lilly USA, LLC15$369
Merck16$304
Johnson & Johnson(2 entities)15$284
AstraZeneca(2 entities)15$256
GSK13$252
Eisai Inc.13$231
Takeda Pharmaceuticals U.S.A., Inc.14$221
E.r. Squibb & Sons, L.L.C.12$201
Genentech USA, Inc.11$195
Amgen6$185
Astellas Pharma US Inc5$165
AVEO Pharmaceuticals, Inc.6$111
Bristol Myers Squibb7$109
ADC Therapeutics America, Inc.6$108
Sumitomo Pharma America, Inc.6$100
Beigene USA, Inc.6$99
Rigel Pharmaceuticals, Inc.8$97
Array Biopharma Inc6$93
Ipsen Biopharmaceuticals, Inc5$92
Tolmar, Inc.4$77
Sanofi4$73
Jazz Pharmaceuticals Inc.4$73
Taiho Oncology, Inc.4$70
Regeneron Healthcare Solutions, Inc.3$66
Blueprint Medicines Corporation4$60
Tersera Therapeutics LLC3$58
Exelixis Inc.3$57
Pharmaessentia USA Corporation2$50
Karyopharm Therapeutics Inc.3$49
Gilead3$49
Beone Medicines USA, Inc.3$47
Tactile Systems Technology Inc3$45
Pharmacosmos Therapeutics Inc.2$39
Bayer2$37
Myovant Sciences Inc.2$33
Stemline Therapeutics Inc.2$33
EMD Serono, Inc.2$32
Sobi, Inc2$31
Morphosys, US Inc.2$30
Myriad Genetic Laboratories, Inc.1$22
Kyowa Kirin, Inc.1$20
Boehringer Ingelheim1$20
Servier Pharmaceuticals LLC1$19
G1 Therapeutics, Inc.1$18
Deciphera Pharmaceuticals Inc.1$18
Novocure Inc.1$15
Foundation Medicine, Inc.1$15
Pharmaand GmbH1$14
Mirati Therapeutics, Inc.1$14
Acrotech Biopharma Inc.1$13
Acceleron Pharma, Inc.1$13

How this compares

$14,690 in reported general payments places this provider in the 95th percentile of 4,059 nurse practitioner providers in Pennsylvania.

See all nurse practitioner providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$27,831
Medicare patients
165
Services billed
427

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nurse practitioner in du Bois

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →